Fertility Services Market by Procedure, Service and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4580514
  • Report
  • Region: Global
  • 166 pages
  • Allied Analytics LLP
1 of 4
Fertility services are treatments, which aid in treating infertility in patients. In vitro fertilization (IVF), surrogacy, artificial insemination, and others are different forms of infertility services, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. The global fertility services market was valued at $16,761 million in 2016, and is estimated to reach at $30,964 million by 2023, registering a CAGR of 9.3% from 2017 to 2023.

The global fertility services market is expected to witness a substantial growth in future owing to rising incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in fertility procedures, and increased occurrences of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of fertility treatments, increase in disposable income, and favorable reimbursement policies further augment the market growth.

Recent innovations in IVF technology, such as embryoscope and capsule IVF, are anticipated to augment the demand of fertility devices in future. However, strenuous maintenance issues, high cost of devices, multiple pregnancies, and ethical considerations are projected to hinder the market growth. Increase in upsurge of fertility clinics and same sex marriages are projected to offer lucrative growth opportunities in future. In addition, fertility tourism is expected to provide ample growth opportunities especially in the developing economies.

The global fertility services market comprises four key segments namely, procedures, services, end users, and geography. The procedures market considered in this report include, in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), and others. Based on services, the global fertility services market is categorized into fresh non-donor, frozen non-donor, egg and embryo banking, fresh donor, and frozen donor. The global IVF devices market by end users is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
Market estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Procedure

IVF with ICSI
Surrogacy
IVF without ICSI
IUI
Others (GIFT and ZIFT)

By Service

Fresh Non-Donor
Frozen Non-Donor
Egg and Embryo Banking
Fresh Donor
Frozen Donor

By End User

Fertility clinics
Hospitals
Surgical centres
Clinical research institutes

Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

The list of key players operating in this market include:

Apollo Hospitals Enterprise Ltd
Care Fertility Group
Carolinas Fertility Institute
Genea Limited
The Johns Hopkins Health System Corp
Medicover Group
Monash IVF Group
OvaScience Inc.
Progyny Inc.
Xytex Cryo International
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.2.3. Top Winning Strategies, By Company, 2015-2017
3.3. PORTERS FIVE FORCE ANALYSIS
3.4. GOVERNMENT REGULATIONS
3.4.1. U.S.
3.4.1. Europe
3.5. INSURANCE REIMBURSEMENT SCENARIO
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Continuous decline in fertility rates
3.6.1.2. Delayed pregnancies in women
3.6.1.3. Technological advancements with respect to fertility treatment
3.6.2. Restraints
3.6.2.1. High treatment costs of ARTs in developed countries
3.6.2.2. Inadequate reimbursement policies
3.6.3. Opportunity
3.6.3.1. Rise in fertility tourism

CHAPTER 4 FERTILITY SERVICES MARKET, BY PROCEDURE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. IVF WITH ICSI
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. IUI
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. IVF WITHOUT ICSI
4.4.1. Key market trends growth factors, and opportunities
4.4.2. Market size and forecast
4.5. SURROGACY
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.6. OTHERS
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast

CHAPTER 5 FERTILITY SERVICES MARKET, BY SERVICE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. FRESH NON-DONOR
5.2.1. Market size and forecast
5.3. FROZEN NON-DONOR
5.3.1. Market size and forecast
5.4. EGG AND EMBRYO BANKING
5.4.1. Market size and forecast
5.5. FRESH DONOR
5.5.1. Market size and forecast
5.6. FROZEN DONOR
5.6.1. Market size and forecast

CHAPTER 6 FERTILITY SERVICES MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. FERTILITY CLINICS
6.2.1. Market size and forecast
6.3. HOSPITALS
6.3.1. Market size and forecast
6.4. SURGICAL CENTERS
6.4.1. Market size and forecast
6.5. CLINICAL RESEARCH INSTITUTES
6.5.1. Market size and forecast

CHAPTER 7 FERTILITY SERVICES MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by procedure
7.2.4. Market size and forecast, by service
7.2.5. Market size and forecast, by end user
7.2.5.1. U.S. market size and forecast
7.2.5.2. Canada size and forecast
7.2.5.3. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by procedure
7.3.4. Market size and forecast, by service
7.3.5. Market size and forecast, by end user
7.3.5.1. Germany market size and forecast
7.3.5.2. France market size and forecast
7.3.5.3. UK market size and forecast
7.3.5.4. Italy market size and forecast
7.3.5.5. Spain market size and forecast
7.3.5.6. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by procedure
7.4.4. Market size and forecast, by service
7.4.5. Market size and forecast, by end user
7.4.5.1. Japan market size and forecast
7.4.5.2. India market size and forecast
7.4.5.3. China market size and forecast
7.4.5.4. Australia market size and forecast
7.4.5.5. South Korea market size and forecast
7.4.5.6. Taiwan market size and forecast
7.4.5.7. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by procedure
7.5.4. Market size and forecast, by service
7.5.5. Market size and forecast, by end user
7.5.5.1. Brazil market size and forecast
7.5.5.2. Turkey market size and forecast
7.5.5.3. Saudi Arabia market size and forecast
7.5.5.4. South Africa market size and forecast
7.5.5.5. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES
8.1. APOLLO HOSPITALS ENTERPRISE LTD.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. CARE FERTILITY GROUP
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Key strategic moves and developments
8.3. CAROLINAS FERTILITY INSTITUTE
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.4. GENEA LIMITED
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. THE JOHNS HOPKINS HEALTH SYSTEM CORP.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. MEDICOVER GROUP
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. MONASH IVF GROUP
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. OVASCIENCE INC.
8.8.1. Company overview
8.8.2. Product portfolio
8.8.3. Business performance
8.8.4. Key strategic moves and developments
8.9. PROGYNY INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Key strategic moves and developments
8.10. XYTEX CRYO INTERNATIONAL
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Product portfolio
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, "Fertility Services Market by Procedure, Service, and End User: Global Opportunity Analysis and Industry Forecast, 2014-2023, "the global fertility services market was valued at $16,761 million in 2016, and is projected to reach $30,964 million by 2023, growing at a CAGR of 9.3% from 2017 to 2023. Europe is anticipated to be the highest revenue contributor throughout the forecast period.

Fertility services are services availed by people who are unable to conceive naturally. These services help infertile couples, single parents, and LGBT community to procreate and start a family. In vitro fertilization and other assisted reproductive technology (ART) procedures, surrogacy, and artificial insemination are some of the widely executed fertility services.

The fertility service market is anticipated to grow considerably in the near future owing to different factors such as increase in infertility rates, changes in lifestyle, and surge in incidence of male infertility cases. Low awareness with respect to fertility services in emerging markets restrict the market growth. Rise in prevalence due to increase in risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities for market growth during the forecast period.

In the procedures segment, surrogacy accounted for nearly one-sixth share of the global fertility services market in 2016. In terms of services, egg and embryo banking accounted for a global revenue of nearly one-tenth share in 2016. This segment would exhibit a prominent growth rate owing to its crucial role in preservation of embryos, which is one of the essential factors for a successful assisted reproductive technology procedure.

In the fertility services market, fertility clinics generated revenue of $8,775.8 million in 2016, highest amongst all end users. The segment of surgical centers would exhibit prominent growth rate due to availability of various fertility procedures under one roof, development of fertility devices with advanced technologies and the availability of a skilled workforce. By region, Europe generated the highest revenue in the global fertility services market in 2016.

Key findings of the Fertility Services Market:

Fresh non-donor services accounted for nearly half of the share of the fertility services market in 2016.
Intrauterine insemination (IUI) are anticipated to grow with the highest CAGR throughout the forecast period.
Europe accounted for approximately one-third share of the global IVF devices and consumables market in 2016.
The Asia-Pacific region is anticipated to be the fastest growing fertility services market during the analysis period, followed by LAMEA.

The report provides extensive competitive analysis and profiles of key market players, such as Apollo Hospitals Enterprise Ltd, Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, OvaScience Inc., Progyny Inc., and Xytex Cryo International The other players in the value chain (not included in the report) include Irvine Scientific, INVO Bioscience, LifeGlobal Group, and IVFtech ApS.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll